List of SBIR/STTR awards granted to Apricity Therapeutics
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Apricity Therapeutics in September, 2020 for $168,000.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration. | SBIR | 1R43FD006909-01 | Phase I | 168,000 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Apricity Therapeutics in June, 2019 for $223,334.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM131477-01 | Phase I | 223,334 | June 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Apricity Therapeutics in September, 2022 for $168,400.0 USD from the U.S. Department of Health & Human Services and Food and Drug Administration. | SBIR | 1R43FD007586-01 | Phase I | 168,400 | September 20, 2022 | |||||||
A SBIR Phase I contract was awarded to Apricity Therapeutics in May, 2017 for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA206705-01A1 | Phase I | 225,000 | May 17, 2017 | |||||||
A SBIR Phase I contract was awarded to Apricity Therapeutics in September, 2016 for $216,990.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA177013-01A1 | Phase I | 216,990 | September 7, 2016 | |||||||
A SBIR Phase I contract was awarded to Apricity Therapeutics for $172,738.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA174132-01 | Phase I | 172,738 | ||||||||
A SBIR Phase I contract was awarded to Apricity Therapeutics for $190,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA183186-01 | Phase I | 190,000 |
